SPDR® S&P Biotech ETF (XBI)

93.00
Delayed Data
As of May 25
 +0.27 / +0.29%
Today’s Change
66.66
Today|||52-Week Range
97.98
+9.58%
Year-to-Date

Investment Objective

The investment seeks to provide investment results that- before fees and expenses- correspond generally to the total return performance of the S&P Biotechnology Select Industry Index derived from the biotechnology segment of a U.S. total market composite index. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index")- the fund employs a sampling strategy. It generally invests substantially all- but at least 80%- of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.

Performance

1 month+7.91% 3 years+6.45%
3 months+0.57% 5 years+21.04%
1 year+33.95% Since inception+15.49%
Data through 05/26/2018

Quote Details

Previous close$92.73
Open day’s range92.36 – 93.41
Net asset value (NAV)93.10 (05/25/2018)
Daily volume2,728,662
Average volume (3 months)4,703,381
Data as of 8:00pm ET, 05/25/2018

Peer Comparisonvs. Health ETFs

 XBICategory
Performance 5-yr return+21.04%+14.29%
Expense Gross exp ratio0.35%1.29%
Risk 5 year sharpe ratio0.740.89
Net assets$4.9B$2.9B
Average market cap$3.2B$9.8B
Average P/E--22.0
Dividend / Share--0.30%

Competitors

FHLC Fidelity® MSCI Health Care Index ETF
XLV Health Care Select Sector SPDR® Fund
VHT Vanguard Health Care Index Fund ETF Shar...

Holdings

Top 5 Sectors
Portfolio weighting
Healthcare 100.00%
Business service 0.00%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
-- 2.36%
ONCE Spark Therapeutics Inc1.89%
ICPT Intercept Pharmaceuticals Inc1.62%
IMMU Immunomedics Inc1.61%
SRPT Sarepta Therapeutics Inc1.56%
ADMS Adamas Pharmaceuticals Inc1.56%
AGIO Agios Pharmaceuticals Inc1.52%
BMRN Biomarin Pharmaceutical Inc1.52%
LOXO Loxo Oncology Inc1.49%
EXAS Exact Sciences Corp1.46%